Bumper Offer - Urjas oil Just @ Rs. 1 X
Levroxa 250 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Epilepsy are some of its major therapeutic uses. Levroxa 250 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Levroxa 250 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Levroxa 250 Mg Tablet also has some side effects, the most common being Fatigue, Headache, Drowsiness. Besides the aforementioned side effects, there are other adverse effects of Levroxa 250 Mg Tablet as well, which are listed below. Normally, these side effects of Levroxa 250 Mg Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Levroxa 250 Mg Tablet has a Moderate effect for pregnant women and Mild effect on lactating mothers. It is important to know if Levroxa 250 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Levroxa 250 Mg Tablet related warnings section.
Other conditions have been mentioned below in the Levroxa 250 Mg Tablet contraindications section.
Drug interactions for Levroxa 250 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Levroxa 250 Mg Tablet is not safe while driving, and is not addiction.
Levroxa 250 Mg Tablet is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levroxa 250 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Levroxa 250 Mg Tablet safe for pregnant women?
Levroxa can have harmful effects in pregnant women. If you experience any discomfort after using Levroxa, then discontinue the use and take your doctor's advice.
Is the use of Levroxa 250 Mg Tablet safe during breastfeeding?
Side effects of Levroxa on breastfeeding women are very mild.
What is the effect of Levroxa 250 Mg Tablet on the Kidneys?
Levroxa may have mild side effects on the kidneys.
What is the effect of Levroxa 250 Mg Tablet on the Liver?
Levroxa has very mild side effects on the liver.
What is the effect of Levroxa 250 Mg Tablet on the Heart?
Levroxa is completely safe for the heart.
Levroxa 250 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levroxa 250 Mg Tablet unless your doctor advises you to do so -
Is this Levroxa 250 Mg Tablet habit forming or addictive?
No, you will not get addicted to Levroxa 250 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Levroxa 250 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Levroxa 250 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, Levroxa 250 Mg Tablet is useful in treating mental disorders.
Interaction between Food and Levroxa 250 Mg Tablet
Taking Levroxa 250 Mg Tablet with food is safe.
Interaction between Alcohol and Levroxa 250 Mg Tablet
Consumption of alcohol and Levroxa 250 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420